I nnate immunity evolved approximately 2.6 billion years ago as a rapid, nonspecific, redundant, multifunctional, "failsafe" host defense system. 1,2 A plethora of effector molecules including antimicrobial peptides (AMPs: defensins, defensinlike chemokines, and cathelicidin) and proteins (CAP-37), alone and in combination, demonstrate inhibitory activity against a wide variety of pathogens, including bacteria, fungi, parasites, and some viruses. 3, 4 In addition, AMPs serve as important effector molecules in inflammation, immune activation, and wound healing. 5, 6 Naturally occurring AMPs are secreted by various epithelia in skin and mucosal surfaces, including the ocular surface, 7, 8 and are also found in circulating phagocytes. Modified and synthetic AMPs comprise a potential new class of drugs and are in various stages of development for a variety of topical and systemic applications. 9, 10 Microarray technology has facilitated the monitoring of host cell responses to viral infection, including adenovirus, 11 HSV-1, 12 hCMV, 13 HIV, 14 KSHV, 15 human papilloma virus, 16 hepatitis C virus, 17, 18 and dengue virus. 19 Collectively, these studies have advanced our understanding of host interaction with these important human pathogens. Of particular interest is the balance between host defense and viral immune evasion during acute and chronic infections. 20 -22 Elucidation of the virus lytic cycle, viral perseverance, and latency are also topics of interest.
However, with one exception, 11 the infection of human ocular cells by wild-type adenovirus remains unaddressed by microarray analysis. Studies of nonocular cells or ocular cell lines [23] [24] [25] [26] may incompletely reflect host cell response in vivo. In the literature, studies of recombinant adenovirus vectors 24 -26 are favored over those of pathogenic strains, because the former have potential use in gene therapy. Moreover, in most studies, unphysiologically high infectivity titers 23, 26 were used, and so these studies do not accurately model naturally occurring eye infections.
In the present study, we focused on infection at the ocular surface by treating primary cultured human conjunctival epithelial cells with a pathogenic clinical ocular isolate of Ad5. This was accomplished at multiplicities of infection (MOI) sufficiently low (0.1 or 1.0) to mimic clinical infection closely. Host expression was characterized using oligonucleotide microarrays (GeneChips; Affymetrix, Santa Clara, CA), and transcripts that were elevated at MOI ϭ 0.1 (host defense predominates) relative to MOI ϭ 1.0 (viral control predominates) were designated as host antiviral genes. Based on the existing literature, we hypothesized that ␤-defensins, which are active against HIV, [27] [28] [29] would appear in this host antiviral group and would show direct antiviral effects against Ad5. This was not the case, however. The speculated role of ␤-defensins was filled by IP-10 and ITAC, defensin-like chemokines with direct antiviral effects.
essential medium with Earle's salts (Cell Culture Reagents; SigmaAldrich, St. Louis, MO), supplemented with 10% fetal bovine serum (Harlan Bioproducts for Science, Indianapolis, IN), 2.5 g/mL amphotericin B, 100 u/mL penicillin G, and 0.1 mg/mL streptomycin (SigmaAldrich), hereafter known as OG.
All primary cell cultures were prepared in the departmental Core Hybridoma and Tissue Culture Module by a dedicated technician. Human donor eyes deemed unsuitable for transplantation were obtained from the Center for Organ Recovery and Education (CORE, Pittsburgh, PA), in accordance with the provisions of the Declaration of Helsinki for research involving human tissue. Conjunctival tissue was harvested under sterile conditions by an experienced corneal surgeon (YJG). Conjunctival epithelial cells were grown in primary culture over 1 to 3 weeks by using established procedures 30, 31 and then were used for gene array experiments.
Virus Serotypes and Peptides
Adenovirus serotype 3 (Ad3) was purchased from the American Type Culture Collection (ATCC; Manassas, VA). Adenovirus serotypes 5, 8, and 19 were clinical isolates cultured from patients who presented with typical adenovirus ocular disease at the Eye and Ear Institute of Pittsburgh and were typed by serum neutralization. The isolates were grown in A549 monolayers at 37°C, in a 5% CO 2 -water vapor atmosphere, harvested, aliquoted, and frozen as a virus stock at Ϫ70°C. HSV-1 McKrae was grown in Vero cell monolayers and processed the same as the adenovirus stocks. Before use, the stock viruses were titered with a standard plaque assay.
Human defensins ␣1, -␤1, and -␤2 were purchased from Peptides International (Louisville, KY), whereas IP-10 and I-TAC were purchased from Cell Sciences (Canton, MA). All peptides were stored at Ϫ20°C before use and reconstituted according to the manufacturers' instructions on the day the experiment was performed.
Gene Microarray Analysis
Cultured primary human conjunctival epithelial cells were treated with the clinical isolate of Ad5 at multiplicities of infection (MOI) of 0, 0.1, or 1.0 and harvested at 1.5, 6, or 16 hours after infection. Total RNA was isolated from cultured cells (RNeasy/Qiashredder systems; Qiagen Inc., Valencia, CA), with a yield of 46 Ϯ 14 g (mean Ϯ SD, n ϭ 9) RNA per 60-mm culture dish. Total RNA was processed and analyzed (HU133A GeneChips; Affymetrix Inc., Santa Clara, CA). The mRNA component of the total RNA was reverse transcribed (SuperScript system; Invitrogen Corp., Carlsbad, CA) in the presence of a T7-(dT)24 primer. The resultant cDNA was extracted with phenol-chloroform, ethanol-precipitated from the aqueous phase, and transcribed in vitro in the presence of biotin-labeled ribonucleotides using (BioArray kit; Enzo Biochem, Inc., Farmingdale, NY). The biotinylated RNA was separated from cDNA and other transcription components (RNeasy; Qiagen), 20 g was fragmented (35 minutes at 94°C in Affymetrix sample fragmentation buffer), and the fragments were hybridized to a microarray (GeneChip; Affymetrix). The chip was then washed and developed before it was read in a scanner (ChipScanner; Affymetrix Inc.). Raw data were processed and analyzed on computer (Microarray Analysis Suite [MAS] ver. 5.0; Affymetrix) with software that uses nonparametric algorithms to determine (1) whether a transcript is present or absent on a single microarray (P Ͻ 0.04) and (2) in comparing any two microarrays, whether the signal change is significantly increased or decreased (P Ͻ 0.006).
Real-Time PCR Analysis
Quantitative real-time PCR (QRT-PCR) assays were performed with a sequence detector (Prism 7700 Sequence Detector; Applied Biosystems, Inc.
[ABI], Foster City, CA) running 96-well plates at 50 L/well final volume. Instrument control and data analysis were made using the default settings of the supplied software (Primer Express v. 1.5a; ABI). Each assay comprised triplicate measurements of cDNA generated by the microarray protocol, using ϳ10 ng nucleic acid per well and duplicate measurements of (minus RT) control. Samples were mixed with PCR master mix (TaqMan Universal; Roche, Branchburg, NJ) and the appropriate primer-probe kits (Assays-on-Demand; ABI). The following kits were used (HGNC symbols and ABI catalog numbers): CXCL10 (as SCYB10), Hs00171042_m1; CXCL11 (as SCYB11), Hs00171138_m1; DEFB1, Hs00174765_m1; RSAD2/viperin (as cig5), Hs00369813_m1; RRM2, Hs00357247_g1; ACTB, Hs99999903_m1. The relative level of transcripts was calculated using the ⌬⌬C t method using the housekeeping gene ␤-actin (ACTB) as endogenous control.
Direct Antiviral Inhibition Studies
Stock solutions of defensins (400 g/mL) or IP-10/I-TAC (222.22 g/ mL) were made in distilled water with a subsequent twofold dilution using 2ϫ PBS. Frozen viral stocks were thawed in a 37°C water bath and diluted in serum-and antibiotic-free OG to yield approximately 10 2 and 10 5 pfu/mL. Virus and peptide stocks were mixed to produce final peptide concentrations of 100 g/mL and 10 2 and 10 5 pfu/mL. The virus/peptide combinations were incubated in a 37°C water bath for 60 (defensins) or 75 (IP-10/I-TAC) minutes to assess the direct antiviral effect. After incubation, each virus/peptide mixture and control was either added directly to A549 monolayers (defensins) or diluted in ice-cold tissue culture medium containing 10% fetal bovine serum before addition (IP-10/I-TAC). After viral adsorption for 3 hours at 37°C and 5% CO 2 with constant rocking, the appropriate overlay medium was added to the monolayers. The plates were incubated at 37°C, 5% CO 2 and examined daily for plaques (viral cytopathic effect). When plaques were visible, the multiplates were stained with gentian violet and counted with a 25ϫ dissecting microscope. In the IP-10/I-TAC assays unincubated virus-PBS standards were used to check the viral plaque-forming units for each assay, and if the plaque-forming units recovered from incubated virus-PBS controls was Ͻ20% of the unincubated virus-PBS standards, then data from that assay were discarded. The plaque-forming unit titer of each virus/peptide combination was reported as a fraction of the matched virus-PBS control for two to four independent experiments. Virus/peptide data were first compared with incubated virus-PBS control using Student's t-test. Because multiple comparisons (one per peptide) are made with each PBS control, we also checked using the more appropriate Dunnett's test, which confirmed the t-test results.
RESULTS

Identification of Antiviral Genes in Cultured Human Conjunctival Epithelial Cells by Gene Array Analysis
We reasoned that a high MOI (1.0) would lead to successful infection of a substantial proportion (ϳ60%) of conjunctival cells in the culture and a robust, targeted downregulation of antiviral genes would occur as a part of a viral immune evasion strategy. In contrast, infection at a lower MOI (0.1) would lead to successful infection of a smaller percentage of cells and that these infected cells would signal adjacent, uninfected cells via interferon, to activate antiviral genes, including secreted innate immune proteins. Of the 22,215 host cell panels on the microarray chip (U133A; Affymetrix), 9,068 were absent in all nine samples and were excluded from further consideration. In the remaining panels, 1294 (ϳ10%) showed at least one twofold change. From these we selected panels in which the host defense response evoked by low MOI was robustly and significantly suppressed by high MOI (MOI [0.1])/MOI [1.0]) Ն2, P Ͻ 0.003, MAS ver. 5.0). These criteria were met by 37, 17, and 57 microarray panels at 1.5, 6, and 16 hours after infection, respectively. We focused on the largest group (16 hours), which contained a high percentage of interferon-dependent transcripts. Accordingly, the 16 hours samples were reassayed using U133B chips and another 23 panels were found fulfilling the same criteria. Of the total of 80 panels, 10 were characterized only by their panel numbers (see legend to Table 1 ). The remaining 70 characterized panels represented 63 unique transcripts that were divided by function into nine groups: secreted products (n ϭ 5, 8%), IFN-or virus-induced (n ϭ 21, 33%), IFN signaling (n ϭ 2, 3%), transcriptional control (n ϭ 7, 11%), receptor and integral membrane proteins (n ϭ 3, 5%), apoptosis (n ϭ 4, 6%), enzymes (n ϭ 2, 3%), unassigned (n ϭ 15, 24%), and unknown (n ϭ 4, 6%). For brevity we included in Table 1 only the 49 panels for which one or both of the infected samples' value was also significantly different from the uninfected sample. The 21 panels omitted from Table 1 include the toll-like receptor 3, IFN-induced IFIT2, and an additional panel for RSAD2/viperin.
Transcripts in Table 1 that are marked with an asterisk also were suppressed twofold by an MOI of 1.0 at the earliest time studied (1.5 hours after infection), confirming that Ad5 attempts to suppress antiviral host cell defenses very early in the infection process. Thirteen (72%) of these 18 suppressed transcripts are IFN dependent. Of the secreted chemokines, two (CXCL10 and CXCL11) are IFN dependent, whereas two (CXCL2 and CXCL5) are TNF-␣ dependent.
Expression data were examined for other innate immune genes. ␣-Class defensins (hDEF1A, hDEF4A, hDEF5A, and hDEF6A) are present in circulating phagocytes but absent from conjunctival epithelia and were not detected in the present study. Transcripts of the CAMP gene encoding cathelicidin (LL37) also were undetectable. We have shown previously 57 that CAMP transcripts are detectable by RT-PCR in both corneal and conjunctival epithelial cells, so their apparent absence here is probably due to the known lower sensitivity of gene arrays relative to RT-PCR. Similarly, CAP37 reported as a corneal AMP 58 was not detected in the present study. However, for transcripts present at higher concentrations, gene arrays and quantitative RT-PCR (QRT-PCR) gave comparable results (Fig. 1 ).
Time Course of Innate Immune Gene Expression in Conjunctival Epithelial Cells
The gene array data provided a time-course of expression for each MOI. For selected genes, we confirmed the time course using QRT-PCR (Figs. 1) . Transcripts of the genes CXCL10, CXCL11, and RSAD2, respectively encode the defensin-like chemokines IP-10 and I-TAC and the intracellular antiviral protein viperin. QRT-PCR data confirmed the early (1.5 hours) downregulation of all three transcripts in infected cells, as well as the upregulation at 16 hours, when MOI ϭ 0.1. Figure 1D summarizes the expression of ␤-defensin-1 (DEFB1) which was suppressed at 6 and 16 hours. Qualitatively similar gene array data (not shown) were obtained for ␤-defensin-2; however, at the time of the study, no QRT-PCR kit was available to confirm the DEFB2 changes.
The modest (ϳ2-fold) changes shown in Figure 1 led us to confirm examples from other data groups that showed more substantial changes. Members of the carcinoembryonic antigen cell adhesion molecule (CEACAM) family, CEACAM5 and CEACAM7 are presumptive innate immune molecules 59 in epithelial cells. Gene array data showed both were substantially increased by viral infection at 1.5 hours, an increase that was confirmed by QRT-PCR for CEACAM7 (Fig. 1E) .
Finally, review of the microarray data revealed that 109 panels, representing 96 unique transcripts, comprised a viral footprint-that is, were increased twofold or more by MOI 1.0 vs. MOI 0.0 (mock-infected) at 16 hours (data not shown). More than half (55, 57%) represent adenovirus upregulation of host proliferation systems. Twenty-five (26%) of these transcripts respond to host transcription factor E2F, which is itself a target for adenovirus E1A protein. 60 An example of this group is RRM2 (ribonucleotide reductase subunit 2) which is E2F-responsive and fulfills adenovirus' dependence on host ribonucleotide reductase. 61 As expected, both techniques show that RRM2 is substantially increased by viral infection at 16 hours (Fig. 1F) .
Direct Incubation Antiviral Assays
The defensin-like chemokines IP-10 and I-TAC, identified as antiviral host genes (Table 1) , were assayed for antiviral activity in vitro (Fig. 2) against Ad serotypes with different preferred targets (tissue tropisms) but all capable of infecting the eye. Representative serotypes of group B (Ad3) and group C (Ad5) are known to infect the oropharynx and respiratory system preferentially, but can produce a mild, self-limiting conjunctivitis. In contrast, group D serotypes, Ad8 and Ad19, are highly specific for the eye and generally cause a more serious keratoconjunctivitis with possible long-term visual sequelae. 62 Figure  2 shows that the viral titers representing the respiratory serotypes, Ad3 and Ad5, are both significantly inhibited by IP-10, the peptide product of CXCL10; only Ad3 is significantly inhibited by I-TAC, the peptide product of CXCL11. In contrast, neither IP-10 nor I-TAC demonstrated any significant inhibitory activity against the ocular adenoviral serotypes Ad8 and Ad19, or against HSV-1, another ocular viral pathogen. Figure 3 summarizes the antiviral activity of selected defensins, in the same assay. Human ␣ defensin-1 (HDEFA1) significantly decreased viral titers for the respiratory serotypes Ad3 and Ad5, but had no inhibitory effect on the ocular serotypes, Ad8 and Ad19. The ␤-defensins hDEFB1 and hDEFB2, which are present in human conjunctival and corneal epithelial cells were ineffective against either the respiratory or ocular serotypes.
DISCUSSION
The study of viral pathogenesis has advanced rapidly in recent years after the application of gene array technology. The coevolution of the host cell and virus has been investigated for many important human pathogens HSV-1, 12 hCMV, 13 HIV, 14 KSHV, 15 human papilloma virus, 16 hepatitis C virus, 17, 18 and dengue virus. 19 Of particular interest has been the elucidation of details of the life cycle of the virus, host cell antiviral defenses, and successful viral immune evasion strategies. Adenovirus pathogenesis has been studied in vitro 11 and in respiratory 63 and ocular animal models. 64, 65 The principal immune evasion strategies have been categorized as follows: (1) inhibition of the interferon response, (2) inhibition of multiple apoptosis pathways, and (3) inhibition of cellular immune responses by blocking MHC 1 cell surface molecules, CTLmediated cell lysis, and NK cell activity. 21, 66, 67 In the present study, inhibition of the IFN response attenuated the innate immune response, decreasing expression of antimicrobial peptides (defensin-like chemokines and defensins). In addition, unlike previous studies, we chose conditions for our gene array studies that more closely mimicked conditions of naturally occurring ocular infections: (1) a differential MOI strategy to identify host antiviral genes, (2) use of a pathogenic clinical ocular isolate, (3) use of conjunctival epithelium as the target cell, (4) use of primary cell cultures from fresh whole eyes, and (5) appropriate times of analysis after infection. At 1.5 hours after infection the virus has penetrated the cell, achieved nuclear localization, and commenced early transcription (viral genes E1A, E2A, E4). By 6 hours, late viral transcription is in progress, with a viral blockade in place, both of host mRNA transport and host translation. Host apoptosis is also The data are sorted into functional groups and are also assigned to one of three different classes (A-C). In class A (21 transcripts) the differences among all three MOIs were significant. In class B (16 transcripts), the MOI (0.1) was not significantly different from MOI (0), so a decrease in MOI (1.0) was predominantly responsible for the change in MOI (0.1)/MOI (1.0). In class C (12 transcripts), the MOI (1.0) was not significantly different from MOI (0), so an increase in MOI (0.1) was predominantly responsible for the change in MOI (0.1)/MOI (1.0). For a further 21 transcripts, MOI (0.1) vs. MOI (1.0) was the only significant difference. These are omitted for brevity. Ten uncharacterized Affymetrix panels were altered but are omitted from the table: 214329_x_at, 224646_x_at, 233722_at, 233890_at, 234136_at, 234330_at, 235183_at, 241245_at, 241569_at, and 241859_at. Affymetrix, Santa Clara, CA. * Also suppressed twofold by an MOI of 1.0 at the earliest time studied. blocked, and S-phase is induced in the host cell to facilitate viral DNA replication. Finally, by 16 hours viral assembly is in full swing, the host cytoskeleton is disrupted, and host interferon and MHC defenses are blocked. At this time host cell lysis and release of mature virus is 2 to 4 hours away.
We compared the present data with the only other microarray analysis of adenovirus effects in ocular cells, Natarajan et al. 11 At 2 hours after infection in human corneal fibroblasts, they surveyed 1176 transcripts and found 58 upregulated and 14 downregulated in infected versus uninfected cells, a discovery rate of (72/1176 ϭ 6.1%). At a comparable time point (T1.5), we found that 310 unique transcripts were changed at least twofold in at least one of the three comparisons between different MOIs. There are ϳ13,300 nonredundant characterized transcripts on the U133A chip, giving a discovery rate of (310/13,313 ϭ 2.4%). Because the transcripts surveyed by Natarajan et al. are all likely to be on the microarray chip that we used (U133A GeneChip; Affymetrix) random chance dictates that our data set contains 2.4% of 72 (i.e., ϳ2) of their transcripts. Exact matches between the data sets are BRCA2, RAB2, and F2R. Three matches are not substantially greater than random chance. Natarajan et al. also reported the "transcription-initiation factor TFIID". The TFIID is a complex of the TATA box-binding protein (TBP) with multiple TBP-associated factors (TAFs). Our data contain TAF9L, which we score as an inexact match. The low level of concordance between the present report and that of Natarajan et al. is probably due to their use of a different cell type (corneal fibroblasts versus conjunctival epithelial cells) and an oculotropic viral serotype (Ad19). We are presently conducting experiments using conjunctival epithelial cells and Ad19. Our recent microarray analysis of cultured human corneal fibroblasts (Harvey SAK, et originating cultured keratocytes. Eighteen of these genes were interferon associated, and all 18 were upregulated, suggesting that the corneal fibroblasts used by Natarajan et al. may be intrinsically more resistant to viral infection than the originating keratocytes. Among these 18 transcripts are 14 that appear in Table 1: DDX58, RSAD2, G1P2, GBP1, IFI44, IFI44L, IFIT1,  IFIT2, IFITM1, MX1, MX2 , OAS1, OAS2, and OASL.
It is well established that binding and/or internalization of virus particles can stimulate changes in host gene expression that are independent of those directed by the viral proteome. For example, binding of UV-inactivated human cytomegalovirus to human monocytes induces immunoregulatory gene expression. 68 Furthermore, whereas IFN-␥ upregulates IP-10 expression in murine renal epithelial cells, UV-inactivated Ad5 also upregulates IP-10 by a parallel independent NF-B-signaling pathway, without eliciting a host IFN response. 69 However, the important role of the viral proteome in further modulating host gene expression is clearly demonstrated at 24 hours after infection in microarray experiments in which an intact adenovirus altered expression of 476 transcripts in embryonic lung fibroblasts compared with only 147 (30%) transcripts altered by an adenovirus depleted of genomic DNA. 70 The chemotactic functions of CXCL10 and CXCL11 genes and their peptide products IP-10 and I-TAC, respectively, are well described for their recruitment function of leukocytes (lymphocytes, macrophages, and neutrophils) during inflammation. 71, 72 Although some expression is reported in bacterial, 73 fungal, 74 and protozoan 75 infections, they are expressed principally in response to a wide range of DNA and RNA viruses: recombinant Ad vectors, 44,76 -78 HSV-1, 79,80 hCMV, 81 influenza A, 82 hepatitis C virus, 83 RSV, 84 and HIV. 85 Their dual function of chemoattraction and direct defensin-like killing has only been recently described in bacteria. 86, 87 Yount and Yeaman 88 correctly predicted that CXCL9, CXCL10, and CXCL11 would have antibacterial defensin-like properties based on their discovery of a universal multidimensional signature motif that characterized the structure of all cationic peptides. In the present study, we report for the first time that the antimicrobial activity of FIGURE 2. Direct antiviral effects of IP-10 and I-TAC, the products of CXCL10 and CXCL11. Mixtures containing 10 2 to 10 5 pfu/mL of the virus and 0 or 100 g/mL peptide stocks were incubated at 37°C for 75 minutes, and then used to infect A549 cell monolayers. Data are the mean Ϯ SEM of determinations in two to four independent experiments, except PBS (0 g/mL) control, which includes data from 18 determinations. Symbols: *P Ͻ 0.05, t-test; **P Ͻ 0.01, t-test; ϩP Ͻ 0.05, Dunnett's test; ϩϩP Ͻ 0.01, Dunnett's test. these defensin-like chemokines can be expanded to include the common respiratory adenoviral serotypes, Ad3 and Ad5, but not the ocular serotypes Ad8 or Ad19 or HSV-1, another ocular viral pathogen. The mechanism of the killing action is unknown, but it is unlikely to be the same as for bacteria and enveloped viruses (i.e., permeabilizing lipid membranes, 89 ) as adenoviridae are nonenveloped viruses. Carr et al. 79 have recently shown that CXCL10/IP-10 has no direct protective effect against HSV-1, although the chemokine is absolutely essential in mounting an ocular inflammatory response against the virus.
Recently, there has been a burgeoning interest in the cationic antimicrobial proteins and peptides (␣-and ␤-defensins, cathelicidin, CAP-37) and their role in the innate immune defense of all mucosal surfaces including the eye. 8, 90, 91 Of the defensins tested in the current antiviral study, only hDEFA1, demonstrated statistically significant activity against the respiratory serotypes, Ad3 and Ad5. Other studies have demonstrated significant antiviral inhibitory activity of ␣-defensins against recombinant Ad5 vectors, 25, 92 HSV-1 and 2, 93-95 and HIV. 96 -99 For example, human ␣-defensin 1 at 50 g/mL inhibits Ad5 infection by 97%, whereas human ␤-defensin 2 at the same concentration provides Ͻ10% inhibition. 92 In our study,␣-defensin 1 also was effective against Ad3 but not against Ad8 or Ad19.
In the present study, the human defensin-␤1 and -␤2 genes were expressed by primary conjunctival epithelial cells but were suppressed after Ad5 infection. Their peptides were ineffective against any adenovirus serotype or against HSV-1. However, both ␣-defensin-5 and human ␤-defensin-1 were effective (two-to threefold decrease) against the Ad5-derived vector Av1CF2s when the defensins were transfected into host cells. 25 To our knowledge, this result is consistent with the literature in which no antiviral activity has yet to be shown by ␤-defensins against a replicating wild-type adenovirus. 25 In contrast, ␤-defensins have been reported to inhibit HIV in vitro. 27 The ␤-defensins hDEF-1, hDEF-2, and hDEF-3 show increased expression by conjunctiva and corneal epithelia in response to bacterial infection, proinflammatory cytokines, and injury, 8, 91 and are downregulated in Pseudomonas aeruginosa murine keratitis. 100 The specificity of their antibacterial function on the ocular surface is supported by the present data that they have no substantial antiviral function.
The present data show that IP-10, I-TAC, and hDEFA1 can inhibit the common respiratory adenoviral serotypes, Ad3 and Ad5, but have no effect on the ocular serotypes, Ad8 and Ad19. A preliminary report (Gordon YJ, et al. IOVS 2005; 46 :ARVO E-Abstract 2797) shows that similarly, the antimicrobial protein CAP37 is effective against Ad3 and Ad5, but not against Ad8 or Ad19. Overall, these and other data support the notion of ocular tissue tropism wherein the viral pathogens Ad8 and Ad19 have evolved effective immune evasion strategies to promote replication and transmission in a specific ecological niche-for example, the ocular surface. Preliminary data suggest that the cells' antiviral response (measured by the secretion of IP-10 protein) in response to Ad19 occurs later and is less pronounced than their response to Ad5, which is exactly what one would expect if Ad19 practices immune evasion in the ocular niche. Coevolution generally favors a dynamic equilibrium that is achieved when host-mediated virus clearance is modulated, in part, by successful evasion strategies. Additional gene arrays studies are planned with ocular adenoviral serotypes that infect ocular conjunctival epithelia, to explore these issues.
